Johnson & Johnson
JNJ XNYS
$270.47
+3.33 (+1.25%)
▲
15-min delayed
Open
$270.36
High
$272.50
Low
$269.47
Volume
11.93M
Market Cap
$643.09B
About Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.
TickerDaily Coverage
Stock Market Today, October 30, 2026: S&P 500 Closes Near Flat as Tech Digests Earnings
Market News
Sarah Mitchell · Oct 30, 2026
The stock market closed mixed Friday, October 30, 2026, as the S&P 500 held near flatline while...
Stock Market Today, October 21, 2026: S&P 500 Closes Near Flat as Tech Steadies
Market News
Sarah Mitchell · Oct 21, 2026
Stocks finished mixed on Wednesday, October 21, 2026, with the S&P 500 treading water as investors...
Stock Market Today, October 16, 2026: S&P 500 Closes Higher on Tech Recovery
Market News
Sarah Mitchell · Oct 16, 2026
The stock market finished Friday, October 16, 2026, with broad gains led by technology stocks. The...
Stock Market Today, October 14, 2026: S&P 500 and Nasdaq Close Higher on Fed Pivot Signals
Market News
Sarah Mitchell · Oct 14, 2026
Stocks rallied Wednesday, October 14, 2026, as investors digested softer-than-expected inflation...
Healthcare Stocks This Week: XLV Outpaces S&P 500 Amid Rate Pause Optimism (Oct 5–9, 2026)
Market News
David Brooks · Oct 9, 2026
The healthcare sector navigated a volatile week with conviction, as the XLV ETF gained 2.8% from...
View All Coverage →
Get JNJ Alerts
Stay ahead with breaking news, price alerts, and expert analysis on Johnson & Johnson.
Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.